CA
NZ
UK
AU
IND
US
A statement of changes in beneficial ownership was filed on August 24, 2026, disclosing that Leighton M. Cubbage, a director of Southern First Bancshares Inc, sold 800 shares of common stock on August 20, 2026.
UFP Technologies, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 24, 2026, disclosing updated investor presentation materials under Regulation FD.
Eli Simon, Director and CEO/President/COO of Simon Property Group Inc. (NYSE:SPG), filed a Form 4 on August 24, 2026, disclosing changes in beneficial ownership of Common Stock and OP Units with an earliest transaction date of August 20, 2026.
A Form 4 filed on August 24, 2026, with the U.S. Securities and Exchange Commission shows that Shahar Tamari, Chief Operating Officer and Director of Global-E Online Ltd. (NASDAQ:GLBE), disposed of 24,999 ordinary shares on August 19, 2026, pursuant to a Rule 10b5-1 trading …
Susan Street Whaley, Chief Legal Officer and Secretary of Procter & Gamble Co, filed a Form 4 on August 24, 2026, reporting the sale of 2,238 shares of common stock on August 20, 2026, to cover taxes on a stock award.
Marc S. Pritchard, Chief Brand Officer of Procter & Gamble Co, filed a Form 4 on August 24, 2026, reporting a sale of common stock on August 20, 2026, executed to cover taxes on a stock award.
A Form 4 filed with the SEC on August 24, 2026 discloses that Jon Stephen Eglin, an officer of DHT Holdings, Inc. responsible for Chartering and Operations, sold 25,000 shares of common stock on August 21, 2026.
Marco Nicola D'Ippolito, CEO of Global Private Markets at Patria Investments Ltd, filed a Form 4 on August 24, 2026, reporting three transactions in Class A Common Shares spanning April and August 2026.
Kevin J. McNamara, President and CEO of Chemed Corporation, filed a Form 4 on August 24, 2026, disclosing the sale of 2,000 shares of Chemed Capital Stock on August 21, 2026.
Ashley McEvoy, President and Chief Executive Officer of Insulet Corporation, filed a statement of changes in beneficial ownership on August 24, 2026, reporting an open-market purchase of Insulet common stock transacted on August 21, 2026.
Please wait processing your request...